These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10857157)

  • 1. Efficacy of immunoscintigraphy for detection of lymph node metastases.
    Britton KE; Jan H; al-Yasi AR; Biassoni L; Carroll MJ; Granowska M
    Recent Results Cancer Res; 2000; 157():3-11. PubMed ID: 10857157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
    Fujii T; Yajima R; Tatsuki H; Kuwano H
    Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sentinel lymph node mapping in early-stage breast cancer: technical issues and results with vital blue dye mapping and radioguided surgery.
    Canavese G; Gipponi M; Catturich A; Di Somma C; Vecchio C; Rosato F; Percivale P; Moresco L; Nicolò G; Spina B; Villa G; Bianchi P; Badellino F
    J Surg Oncol; 2000 May; 74(1):61-8. PubMed ID: 10861612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of axillary lymph node metastases from breast cancer by radiolabelled monoclonal antibodies: a prospective study.
    Tjandra JJ; Sacks NP; Thompson CH; Leyden MJ; Stacker SA; Lichtenstein M; Russell IS; Collins JP; Andrews JT; Pietersz GA
    Br J Cancer; 1989 Feb; 59(2):296-302. PubMed ID: 2930695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear medicine approaches for detection of axillary lymph node metastases.
    Bombardieri E; Crippa F; Maffioli L; Draisma A; Chiti A; Agresti R; Greco M
    Q J Nucl Med; 1998 Mar; 42(1):54-65. PubMed ID: 9646646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of Tc-99m-tetrofosmin SPECT/CT in the detection of residual tumors and axillary lymph node metastases in breast cancer patients following neoadjuvant therapy.
    Spanu A; Sanna D; Chessa F; Farris A; Nuvoli S; Madeddu G
    Clin Nucl Med; 2011 Nov; 36(11):997-1002. PubMed ID: 21975387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subareolar injection of technetium-99m nanocolloid yields reliable data on the axillary lymph node tumour status in breast cancer patients with previous manipulations on the primary tumour: a prospective study of 117 patients.
    Maza S; Thomas A; Winzer KJ; Hüttner C; Blohmer JU; Hauschild M; Richter M; Krössin T; Geworski L; Zander A; Guski H; Munz DL
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):671-5. PubMed ID: 14745517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 99mTc-labelled SM3 in the preoperative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection.
    Biassoni L; Granowska M; Carroll MJ; Mather SJ; Howell R; Ellison D; MacNeill FA; Wells CA; Carpenter R; Britton KE
    Br J Cancer; 1998; 77(1):131-8. PubMed ID: 9459158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary study on a new sentinel lymphoscintigraphy agent 99mTc-Rituximab for breast patient].
    Wang XJ; Lin BH; Yang Z; Ouyang T; Li JF; Xu B; Zhang Y; Zhang MY
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):200-3. PubMed ID: 16875605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
    Ali J; Alireza R; Mostafa M; Naser FM; Bahram M; Ramin S
    Hell J Nucl Med; 2011; 14(3):313-5. PubMed ID: 22087458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary node status in breast cancer patients prior to surgery by imaging with Tc-99m humanised anti-PEM monoclonal antibody, hHMFG1.
    Al-Yasi AR; Carroll MJ; Ellison D; Granowska M; Mather SJ; Wells CA; Carpenter R; Britton KE
    Br J Cancer; 2002 Mar; 86(6):870-8. PubMed ID: 11953817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative sonographic classification of axillary lymph nodes in patients with breast cancer: node-to-node correlation with surgical histology and sentinel node biopsy results.
    Cho N; Moon WK; Han W; Park IA; Cho J; Noh DY
    AJR Am J Roentgenol; 2009 Dec; 193(6):1731-7. PubMed ID: 19933672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
    Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
    Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro diagnosis of axillary lymph node metastases in breast cancer by spectrum analysis of radio frequency echo signals.
    Tateishi T; Machi J; Feleppa EJ; Oishi R; Jucha J; Yanagihara E; McCarthy LJ; Noritomi T; Shirouzu K
    Ultrasound Med Biol; 1998 Oct; 24(8):1151-9. PubMed ID: 9833584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.
    Ahn JH; Son EJ; Kim JA; Youk JH; Kim EK; Kwak JY; Ryu YH; Jeong J
    Acta Radiol; 2010 Oct; 51(8):859-65. PubMed ID: 20670083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.